Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Previously Treated Metastatic Pancreatic Adenocarcinoma
NCT00397787Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in pancreatic adenocarcinoma (PDAC), sponsored by National Cancer Institute. Started Nov 2006; status: completed.
02
Drugs
sunitinib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00397787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397787.